Company Quick10K Filing
Teleflex
10-Q 2020-06-28 Filed 2020-07-30
10-Q 2020-03-29 Filed 2020-04-30
10-K 2019-12-31 Filed 2020-02-21
10-Q 2019-09-29 Filed 2019-10-31
10-Q 2019-06-30 Filed 2019-08-01
10-Q 2019-03-31 Filed 2019-05-02
10-K 2018-12-31 Filed 2019-02-21
10-Q 2018-09-30 Filed 2018-11-01
10-Q 2018-07-01 Filed 2018-08-02
10-Q 2018-04-01 Filed 2018-05-03
10-K 2017-12-31 Filed 2018-02-22
10-Q 2017-10-01 Filed 2017-11-02
10-Q 2017-07-02 Filed 2017-08-03
10-Q 2017-04-02 Filed 2017-05-04
10-K 2016-12-31 Filed 2017-02-23
10-Q 2016-09-25 Filed 2016-10-27
10-Q 2016-06-26 Filed 2016-07-28
10-Q 2016-03-27 Filed 2016-04-28
10-K 2015-12-31 Filed 2016-02-25
10-Q 2015-09-27 Filed 2015-10-29
10-Q 2015-06-28 Filed 2015-07-30
10-Q 2015-03-29 Filed 2015-04-30
10-K 2014-12-31 Filed 2015-02-20
10-Q 2014-09-28 Filed 2014-10-29
10-Q 2014-06-29 Filed 2014-07-30
10-Q 2014-03-30 Filed 2014-04-30
10-K 2013-12-31 Filed 2014-02-24
10-Q 2013-09-29 Filed 2013-10-30
10-Q 2013-06-30 Filed 2013-07-31
10-Q 2013-03-31 Filed 2013-04-30
10-K 2012-12-31 Filed 2013-02-22
10-Q 2012-09-30 Filed 2012-10-31
10-Q 2012-07-01 Filed 2012-07-31
10-Q 2012-04-01 Filed 2012-05-01
10-K 2011-12-31 Filed 2012-02-24
10-Q 2011-09-25 Filed 2011-10-25
10-Q 2011-06-26 Filed 2011-07-27
10-Q 2011-03-27 Filed 2011-04-26
10-Q 2010-09-26 Filed 2010-10-27
10-Q 2010-06-27 Filed 2010-07-23
10-Q 2010-03-28 Filed 2010-04-28
10-K 2009-12-31 Filed 2010-02-25
8-K 2020-07-30 Earnings, Regulation FD, Exhibits
8-K 2020-05-27
8-K 2020-05-21
8-K 2020-05-21
8-K 2020-05-01
8-K 2020-04-30
8-K 2020-02-20
8-K 2019-11-15
8-K 2019-10-31
8-K 2019-08-06
8-K 2019-08-01
8-K 2019-05-03
8-K 2019-05-02
8-K 2019-04-05
8-K 2019-02-26
8-K 2019-02-21
8-K 2019-02-18
8-K 2018-12-10
8-K 2018-11-01
8-K 2018-10-04
8-K 2018-07-31
8-K 2018-06-22
8-K 2018-05-31
8-K 2018-05-21
8-K 2018-05-11
8-K 2018-05-04
8-K 2018-05-03
8-K 2018-03-13
8-K 2018-02-22
8-K 2018-02-19

Teleflex Financials

TFX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ResMed (RMD) 19,678 59% 29.6 10% 4,155 2,037 2,699 1,599 419 701 20,719
Teleflex (TFX) 16,169 57% 32.5 7% 6,257 3,404 2,556 1,459 444 551 17,928
Dexcom (DXCM) 14,282 63% -153.6 -8% 2,186 1,421 1,351 845 -171 -90 13,886
Dentsply Sirona (XRAY) 11,909 52% 27.4 2% 8,367 3,308 3,977 2,079 162 477 13,086
Insulet (PODD) 10,214 66% 201.9 1% 1,268 1,118 694 457 17 53 10,780
ABIOMED (ABMD) 8,562 83% 28.3 20% 1,124 133 820 679 221 297 8,412
Novocure (NVCR) 7,902 73% -778.8 -6% 444 253 322 235 -27 -10 7,842
Hill-Rom Holdings (HRC) 7,085 49% 27.4 3% 4,919 3,346 2,907 1,425 152 298 8,166
Haemonetics (HAE) 6,479 47% 39.1 6% 1,191 607 988 465 68 172 6,738
Integra Lifesciences (IART) 5,281 63% 33.0 2% 3,347 1,962 1,506 944 60 181 5,962
Globus Medical (GMED) 5,230 77% 24.0 10% 1,452 113 770 592 146 211 5,063
Penumbra (PEN) 4,900 67% 90.7 7% 614 147 523 353 45 53 4,788
Nuvasive (NUVA) 3,895 72% 27.0 3% 1,840 1,146 831 48 161 4,347
Tandem Diabetes Care (TNDM) 3,612 53% -179.8 -8% 293 126 330 175 -24 -19 3,455
ICU Medical (ICUI) 3,368 38% 21.1 4% 1,638 297 1,291 492 73 144 3,031
Cantel Medical (CMD) 3,193 46% 39.1 2% 1,906 1,174 950 438 42 103 4,044
Nevro (NVRO) 2,616 69% -31.3 -22% 448 250 384 263 -100 -87 2,724
Glaukos (GKOS) 2,258 87% -139.9 -6% 307 117 225 195 -19 -16 2,210
iRhythm Technologies (IRTC) 1,965 75% -37.6 -17% 310 167 198 150 -52 -49 1,841
Merit Medical Systems (MMSI) 1,715 44% 20.9 1% 1,762 812 970 425 19 101 2,119

Balance Sheet ($MM)2010-06-272010-09-262010-12-312011-03-272011-06-262011-09-252011-12-312012-04-012012-07-012012-09-302012-12-312013-03-312013-06-302013-09-292013-12-312014-03-302014-06-292014-09-282014-12-312015-03-292015-06-282015-09-272015-12-312016-03-272016-06-262016-09-252016-12-312017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-312019-03-312019-06-302019-09-29
Cash2872482082023663725845915456353373072813264324222372863033093252763383934764995446896761,018334379346356357271304258
Accounts Receivable291294294290448476465494441756774424846885295296302287274285286273262275274262272283304306346359359374366376382397
Inventory337360339320294311299299285296323333349346334350356353336339347346330339338342316355369382396404405411428446461473
PP&E291292288274255251566263254267627301311321679329343347675310316313656318315322664355369374789390411421890410425430
Assets3,7443,7983,6433,6795,3935,8165,8585,6075,7936,4736,6576,2076,7756,9017,2007,9116,9577,0047,0066,9397,0527,0987,2947,3884,0004,0027,5445,2325,2909,4329,4608,2406,1756,2016,2786,2686,3146,257
Accounts Payable82928583357381388382390840874949589957271747164757468667373706982828592859598107104108101
Long-Term Debt1,1289048868221,0821,0601,1221,1111,1081,1551,1651,2241,1881,0321,5431,6231,4251,3981,4801,5351,6151,5351,5461,6831,3761,3281,2742,1562,1332,2622,3002,1542,1452,0762,1762,0732,1492,016
Liabilities2,1622,0811,8561,7903,4483,4433,5353,5553,5343,6413,6543,6703,6923,7384,8525,0394,8254,9125,0004,9935,0335,1155,2575,2601,8791,8325,4043,0142,9316,9597,0305,6803,7413,6943,7383,6983,6503,404
Stockholders' Equity1,5771,7131,7831,8854,5114,6374,9404,7204,8385,0855,1925,2155,2725,3765,4315,5005,2345,2535,2505,0195,1655,2135,3075,4032,1192,1702,1382,2192,3596,3895,0932,4342,5072,5702,6652,853
Income Statement ($MM)2010-06-272010-09-262010-12-312011-03-272011-06-262011-09-252011-12-312012-04-012012-07-012012-09-302012-12-312013-03-312013-06-302013-09-292013-12-312014-03-302014-06-292014-09-282014-12-312015-03-292015-06-282015-09-272015-12-312016-03-272016-06-262016-09-252016-12-312017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-312019-03-312019-06-302019-09-29
Revenue462443476389391372412388383368419412420414451439468457476429452444485425474456514488529535595587610610642614653648
Cost of Revenue253240288213207194220202193187220211211210226217224-20235207219216224200217214241232238239264256265267276269280273
Gross Profit209203188176184178192186190181199201209204225221244477241223233228260225256242273256290295331331345343366345373376
R&D11111211121213121415211530161814151517131313131215151618202125262626272828
SG&A119124118110112103112113106115415127126115144140147404153140142139148136143140144164159164213215230215228236230
Tax18-6-56201431417181314141423171414011158-81288-10-312231101410-1114-130
Net Income61238178906816821871197305568743563817851787883101776066614078107-4380-257914183229
Cash Flow ($MM)2010-06-272010-09-262010-12-312011-03-272011-06-262011-09-252011-12-312012-04-012012-07-012012-09-302012-12-312013-03-312013-06-302013-09-292013-12-312014-03-302014-06-292014-09-282014-12-312015-03-292015-06-282015-09-272015-12-312016-03-272016-06-262016-09-252016-12-312017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-312019-03-312019-06-302019-09-29
Cash Operating47601426253872-103-4731723506793408789819967671276711512010991107122107134951216097132
Cash Investing-79665-10-12257-4-5932-344-021-49-3231-1-71-37-0-47-40-46-0-12-21-17-982-42-34-774-0-41-18-24-24
Cash Financing-93-200-87131-11-383132126-19314-27-1928513-255-14-1456-11-71-1521-11-76-211,021-104238-1499-70-97-124-43